Effect of chronic pretreatment with the sigma ligand jo 1784 on crf-lnduced changes in behaviour, neurotransmitter and immunological function in the rat

Neuropsychobiology

Volumn 35, Issue 4, 1997, Pages 200-204

  Song, Cai ^a   Earley, Bernadette ^b   Leonard, B E ^c  

^a CARLETON UNIVERSITY   (Canada)

^b GRANGE RESEARCH CENTRE   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Behaviour; Cellular immunity; Neurotransmitters; Sigma ligand JO 1784 CRF; Stress

Indexed keywords

BIOGENIC AMINE; CONCANAVALIN A; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; IGMESINE; NEUROTRANSMITTER; OPIATE AGONIST; PHYTOHEMAGGLUTININ; SEROTONIN; SIGMA OPIATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOPAMINE METABOLISM; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC AMINES; CINNAMATES; CORTICOTROPIN-RELEASING HORMONE; CYCLOPROPANES; HYPOTHALAMUS; LEUKOCYTES; LIGANDS; LYMPHOCYTES; MALE; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0030997935     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119345     Document Type: Article

References (20)

1. Sagratella S, Cotti de Carolis A, Popoli P: Behavioural and clectroenccphalographic interactions between halopcridol and PCP/sigma ligands in the rat, Psychopharmacology 1991: 105:485-491.
2. Zhang J, Chiodo LA, Wetstein JG, Junien JL, Freeman AS: Repeated administration of sigma ligands alters the population activity of rat midbrain dopaminergic neurone, Synapse 1993:13:223-230.
3. Boyce S, Rupniak NM, Cook G, Iversen SD: Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates, Behav Brain Res 1991:42: 115-121.
4. Gue M, Yoneda H, Monnikes YH, Junien JL, Tache Y: Central neuropeptide Y and the sigma ligand JO 1784 reverse corticotropin releasing factor induced inhibition of gastric acid secretion in rats, Br J Pharmacol 1992:107: 642-647.
5. Gue M, Junien JL, Del Rio C, Bruno L: Central neuropeptide Y and the sigma ligand JO 1784 reverse corticotropin releasing factor induced inhibitors of gastric secretion, J Pharmacol Exp Thcr 1992;261:850-855.
6. Lee EH, Tang YP, Chai CY: Stress and corticotropin-releasing factor potentiate center region activity in rat and mouse in the open field, Psychopharmacology 1987.93:320-323.
7. Adamec RE, Savin U, Brown A: The effects of CRF and handling stress on behaviour in the elevated plus maze test of anxiety, J Psycho-pharmacol 1991;5:175-186.
8. Strausbaugh H, Irwin M: Central corticotropin-releasing hormone reduces cellular immunity, Brain Behav Immun 1992:6:11-17.
9. Jain R, Zwickler D, Hollander CS, Brand H, Saperstein A: Corticotropin releasing factor modulates the immune response to stress in rats, Endocrinology 1991:128:1329-1336.
10. Gray J, Laljee B: Sex differences in emotional behaviour in the rat: Correlation between the ‘open field' dcfaecation and avoidance behaviour, Animal Behav 1974;22:856-861.
11. Pellow S, Chopin P, File SE, Briley M: Validation of opemclosed arm entries in an elevated plus maze as a measure of anxiety in the rat, J Ncurosci Methods 1985:14:149-167.
12. Song C, Leonard BE: The effect of olfactory bulbectomy in the rat alone or in combination with anlideprcssants and endogenous factors, on immune function, Human Psychopharma-col 1994;9:135-146.
13. Seyfried CA, Adam, G, Greve T: An automated direct injection HPLC method for the electrochemical/fluorimetric quantification of monoamines and related compound optimized for the screening of a large number of samples, Biomed Chromatogr 1986;1:78-88.
14. Click D, van Redlick D, Levine S: Fluorimetric determination of corticosterone and cortisol on 0.02-0.05 ml of plasma or sub-milligram samples of adrenal tissue, Endcrinologv 1964:74: 653-655.
15. Dunn AJ, Berridge CB: Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catccholamincrgic systems, Pharmacol Biochent Behav 1987.271:685-691.
16. Monnet FP, Blier P, Debonnel G, de Montigny C: Modulation by sigma ligands of NMDA induced 3H-noradrenaline release in the rat hippocampus, Arch Pharmacol 1992:346:32-39.
17. Gudelsky GA, Nash JF: Neuroendocrinological and ncurochentical effects of sigma ligands, Neuropharmacology 1992:31:157-162.
18. Junien JL, Roman FJ, Brussetle G, Pascaud X: JO P84. A novel sigma ligand, potentiates 3H-acetylcholine release from rat hippocampus slices, EurJ Pharmacol 1991:200:343-345.
19. Wolfe SA, de Souza EB: Sigma and phencyclidine receptors in the brain endocrine-immune axis, NIDA Res Monogr 1993:133:95-123.
20. McGrath HE, Wade PM, Kister VK, Quesenberry PJ: Lithium stimulation of HPP-CFC and stromal growth factor production in murine dcxer culture, J Cell Physiol 1992:151: 276-286.